Lovro Kramer
Novartis (Slovenia) · 20 works · 573 citations · h-index 8
Top works
- The Future of Cysteine Cathepsins in Disease Management
- In Vivo Imaging of Mouse Tumors by a Lipidated Cathepsin S Substrate
- γ9δ2T cell diversity and the receptor interface with tumor cells
- Biocompatible nano-gallium/hydroxyapatite nanocomposite with antimicrobial activity
- Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin
- Designing Ga( iii )-containing hydroxyapatite with antibacterial activity
- Identification of a tumor-specific allo-HLA–restricted γδTCR
- Stefin A-functionalized liposomes as a system for cathepsins S and L-targeted drug delivery
- A genome-scale CRISPR deletion screen in Chinese hamster ovary cells reveals essential regions of the coding and non-coding genome
- Visualisierung von Maustumoren mit einem lipidierten Cathepsin‐S‐Substrat
- Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells
- Modulating antibody N-glycosylation through feed additives using a multi-tiered approach
- The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
- Coupling CRISPR interference with FACS enrichment: New approach in glycoengineering of CHO cell lines for therapeutic glycoprotein production
- Overcoming lentiviral delivery limitations in hard-to-transduce suspension cells for genome-wide CRISPR screening
- Structural and Proteomic Analysis of the Mouse Cathepsin B-DARPin 4m3 Complex Reveals Species-Specific Binding Determinants
- Challenges of γ9δ2TCR affinity maturation when using phage display